This new position paper analyses:
- The Global Pharma market size, dynamics and level of profitability
- The evolution of top pharma companies’ cost structure and profitability
- The corporate strategy of pharma companies based on the strategic segments (e.g., Rx-bound, vaccines, biosimilars, generics, OTCs, medical devices) they play in and the countries they focus on, with the help of the Smart Pharma Consulting « Development Strategy Matrix »